SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-017245
Filing Date
2017-04-28
Accepted
2017-04-28 09:31:11
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 367157
2 EXHIBIT 10.4 ex10_4.htm EX-10.4 83447
3 EXHIBIT 31 ex31.htm EX-31 13501
4 EXHIBIT 32 ex32.htm EX-32 5851
  Complete submission text file 0001140361-17-017245.txt   2725931

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ocx-20170331.xml EX-101.INS 344776
6 XBRL TAXONOMY EXTENSION SCHEMA ocx-20170331.xsd EX-101.SCH 28863
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocx-20170331_cal.xml EX-101.CAL 38802
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocx-20170331_def.xml EX-101.DEF 119692
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocx-20170331_lab.xml EX-101.LAB 425236
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocx-20170331_pre.xml EX-101.PRE 232277
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 17791951
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences